DC-SIGN, a lectin, which presents at the surface of immature dendritic cells, constitutes
nowadays a promising target for the design of new antiviral drugs. This lectin recognizes …

The design and preparation of carbohydrate ligands for DC‐SIGN is a topic of high interest
because of the role played by this C‐type lectin in immunity and infection processes. The …

DC-SIGN is a dendritic cell-specific C-type lectin receptor that recognizes highly
glycosylated ligands expressed on the surface of various pathogens. This receptor plays an …

In genital mucosa, different fates are described for HIV according to the subtype of dendritic
cells (DCs) involved in its recognition. This notably depends on the C-type lectin receptor …

DC-SIGN is a receptor protruded from the membrane of immature dendritic cells (DCs) that
participates in the activation of the immune response through the recognition of pathogen …

Dendritic cell-specific, intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is
a C-type lectin expressed specifically on dendritic cells. It is a primary site for recognition …

The C-type lectin DC-SIGN expressed on immature dendritic cells is a promising target for
antiviral drug development. Previously, we have demonstrated that mono-and divalent C …

Antagonists of the C-type lectin DC-SIGN are promising therapeutic agents against viruses
and bacteria. The development of glycomimetic ligands for DC-SIGN has so far proved to be …

Saturation transfer difference NMR spectroscopy (STD-NMR), together with transfer NOE, is
one of the most widespread NMR methods for the study of the interactions between small …

The C-type lectin DC-SIGNR (dendritic cell-specific ICAM-3-grabbing non-integrin-related;
also known as L-SIGN or CD299) is a promising drug target due to its ability to promote …